Use of traditional medicine for the treatment of diabetes in Eastern Uganda: A qualitative exploration of reasons for choice

BMC International Health and Human Rights (Impact Factor: 1.44). 01/2013; 13(1):1. DOI: 10.1186/1472-698X-13-1
Source: PubMed


While there are biomedical drugs for managing diabetes mellitus, some patients with diabetes use traditional medicine. The aim of the study was to explore why patients with diabetes use traditional medicine for the treatment of diabetes.

The study was conducted in Iganga and Bugiri districts in Eastern Uganda using four focus group discussions (FGDs) with patients with diabetes; two with female patients and two with male patients, thirteen key informant interviews (KIIs); nine with health workers working with patients with diabetes and four with herbalists. FGDs and KIIs focused on what respondents perceived as reasons for patients with diabetes taking traditional medicine. Analysis was done using content analysis.

Reasons for taking traditional medicine included finding difficulties accessing hospitals, diabetic drugs being out of stock, traditional medicine being acceptable and available within community, as well as being supplied in big quantities. Others were traditional medicine being cheaper than biomedical treatment and payment for it being done in installments. Traditional medicine was also more convenient to take and was marketed aggressively by the herbalists. Influence of family and friends as well as traditional healers contributed to use of traditional medicine.

Possibilities of putting diabetic drugs at facilities closer to patients need to be considered and health facilities should have a constant supply of diabetic drugs. Community members need to be sensitized on the proper treatment for diabetes mellitus and on the dangers of taking traditional medicine.

Download full-text


Available from: Elizeus Rutebemberwa,
  • Source
    • "Mondal et al. (2012) indicó una escasa información documental en lo que se refiere a estudios etnobotánicos y etnofarmacológicos; los resultados del presente estudio revelaron el uso terapéutico en el control de la diabetes, no reportado previamente para la región. En este estudio, las 12 especies que cuentan con estudios relacionados con sus propiedades hipoglucémicas apoyan firmemente el criterio de selección de las mismas con un enfoque etnomédico, de acuerdo con Rutebemberwa et al. (2013). Independientemente de este aspecto se puede precisar que algunos de los metabolitos presentes en estas plantas pueden explicar su acción hipoglucemiante. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Because of the increase of chronic degenerative diseases, such as Diabetes mellitus (DM), it is necessary and indispensable to carry out pharmacological studies in order to identify and to evaluate plant species that are used in regional traditional medicine for empirical control of DM. Results of an ethnopharmacological research on Mexican plants used for empirical control of DM in a community at the southeast of Mexico are presented in this study. Information was obtained from people at a community of Tabasco, Mexico by means of applying a TRAMIL structured interview, and by reviewing herbarium specimens. A total of 36 plant species that are used in the community to control the DM was found, all of those species are known by one or more local names. Botanical families with more species mentioned by people are Fabaceae, Asteraceae, Cucurbitaceae, Meliaceae and Poaceae. On the basis of their high TRAMIL significant use (TSU), five plant species are distinguished for local DM control, and two of them are the most important: Tradescanthia spathacea Sw. and Manilkara zapota (L.) P. Royen. The importance of using those species in the community emphasizes the need to initiate pharmacological studies on the hypoglycemic activity of them.
    Boletin Latinoamericano y del Caribe de Plantas Medicinales y Aromaticas 03/2015; 14(2):99-112. · 0.33 Impact Factor
  • Source
    • "Chronic diseases and their treatment is poorly understood within traditional and faith based healing systems, and may thus affect medication adherence (de-Graft Aikins et al. 2010). Poor adherence can also be an active process whereby patients choose to deviate from the treatment regimen through a rational decision process in which they weigh the risks and benefits of treatment against any adverse effects (Raum et al. 2012; Rutebemberwa et al. 2013). "
    [Show abstract] [Hide abstract]
    ABSTRACT: Low adherence to prescribed diabetes medications is one of the major reasons to poor glycemic control in developing countries. Therefore, this study attempted to assess the magnitude of medication adherence and factors associated with it among adult persons with diabetes in northwest Ethiopia. This study utilized a cross sectional study design with internal comparison. The study population was adult persons with diabetes attending the Diabetes Referral Clinic of Gondar University Hospital. Adherence was assessed using the eight-item Morisky Medication Adherence Scale (MMAS-8). In addition laboratory tests and chart reviews were carried out to collect relevant data. Ordinary logistic regression was used to identify factors associated with adherence. A total of 391 patients were studied. Based on the MMAS-8 scale, the self-reported adherence to diabetic medication was low for 25.4% [95% CI: 21, 29] of the patients, medium for 28.7% [95% CI: 24, 33], and high for 45.9% [95% CI: 41, 50] of the patients. The Mean (±SD) of glycosylated hemoglobin for the low adherence group was 8.2% (±2.1). It was 8.1% (±2.0), for the medium, and 7.4% (±1.6) for the high adherence group. In the multivariate analysis poor wealth status (AOR = 1.99; 1.15, 3.43), using traditional treatment (AOR = 2.90; 1.03, 8.15), and service dissatisfaction (AOR = 2.23; 1.04, 4.80) were significantly associated with low adherence to prescribed diabetic medications. Over half of the persons with diabetes did not adhere to medications. Adherence was poor among users of traditional treatment and those dissatisfied with services. Developing a more intensive communication strategies and improving the quality of services could improve the level of adherence.
    SpringerPlus 04/2014; 3(1):195. DOI:10.1186/2193-1801-3-195
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: This paper presents an overview of the history and achievements of the Cochrane Consumers and Communication Review Group, part of the international Cochrane Collaboration. It surveys the Group's establishment and structure, the scope of its Cochrane Reviews and the growth in its publication output over its 16-year history. The paper examines the Group's developmental work in interventions and outcomes related to patient communication and involvement, as well as methodological resources for review authors. It also outlines the Review Group's research partnerships with state, national and international agencies, particularly in the areas of chronic disease management, medicines use, public involvement, and vaccines communication. The Group's strong contribution to an evidence-base for health communication and participation are acknowledged.
    Journal of Evidence-Based Medicine 11/2013; 6(4):216-20. DOI:10.1111/jebm.12066
Show more